If you have bought one (or more) Epi-pens between August 24, 2011 and November 1, 2020 you may be eligible for a payment from a class action lawsuit. You will need to submit proof for this class action.
The lawsuit includes Epi-pen, Epi-pen Jr. or select generics, you can submit a claim.
A Settlement of $345,000,000 has been reached between the Class Plaintiffs and the Pfizer Defendants (which are Pfizer, Inc., Meridian Medical Technologies, Inc., and King Pharmaceuticals LLC (f/k/a King Pharmaceuticals, Inc.)). This Settlement does not concern the resolution of the claims against other defendants in the Action, specifically Mylan N.V., Mylan Specialty L.P., Mylan Pharmaceuticals Inc., Viatris Inc., or Heather Bresch (collectively, the “Mylan Defendants”). Those claims remain pending in the Court and trial of those claims is currently scheduled to commence on January 24, 2022.
You will have to submit your claim (with proof) by November 12, 2021.
Follow Me!